Connect with us
European Gaming Congress 2024

Blockchain Press Releases

High-Throughput Screening (HTS) Market worth $44.5 billion | MarketsandMarkets

Published

on

urban-air-mobility-market-worth-$28.5-billion-by-2030-–-exclusive-report-by-marketsandmarkets™

CHICAGO, July 5, 2023 /PRNewswire/ — In the near future, the high-throughput screening (HTS) industry is poised to undergo significant advancements, revolutionizing the field of drug discovery and accelerating scientific research. Enabled by cutting-edge technologies such as artificial intelligence, automation, and robotics, HTS will achieve unprecedented levels of efficiency and productivity. Researchers will have access to vast libraries of compounds, enabling the rapid screening of thousands or even millions of potential drug candidates against specific targets. This streamlined process will expedite the identification of promising compounds, leading to faster drug development and improved treatment options for various diseases. Additionally, HTS will expand beyond traditional pharmaceutical applications and find its way into areas like personalized medicine and agricultural research, facilitating tailored therapies and enhanced crop yield optimization. With continuous innovation and collaboration, the HTS industry will shape the future of scientific discovery, driving breakthroughs that positively impact human health and well-being on a global scale.

High-Throughput Screening (HTS) Market in terms of revenue was estimated to be worth $25.7 billion in 2023 and is poised to reach $44.5 billion by 2028, growing at a CAGR of 11.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. The global high-throughput screening (HTS) market is expected to grow at a CAGR of 11.6% during the forecast period. The growth of this market is driven by increasing R&D spending in the HTS market. Increased R&D spending can serve as a driving force for the HTS market due to expanded drug discovery efforts, a focus on personalized medicine, technological advancements, and collaborative research efforts.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

Browse in-depth TOC on “High-Throughput Screening (HTS) Market”

471 – Tables
49 – Figures
373 – Pages

Advertisement
Stake.com

High-Throughput Screening (HTS) Market Scope:

Report Coverage

Details

Market Revenue in 2023

$25.7 billion

Advertisement
Stake.com

Estimated Value by 2028

$44.5 billion

Growth Rate

Poised to grow at a CAGR of 11.6%

Market Size Available for

Advertisement
Stake.com

2021–2028

Forecast Period

2023–2028

Forecast Units

Value (USD Billion)

Advertisement
Stake.com

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Product & Service, Application, Technology, and End User

Geographies Covered

Advertisement
Stake.com

North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA)

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

Increasing adoption of high-throughput screening technologies in emerging markets

Advertisement
Stake.com

Key Market Drivers

The growing adoption of open innovative models in pharmaceutical & biotechnology companies

The consumables segment accounted for the largest share, by application in the high-throughput screening (HTS) market in 2022.

On the basis type of product & service, the high-throughput screening market is broadly segmented into consumables , instruments, services, and software. In 2022, consumables accounted for the largest share of the high-throughput screening market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research.

The drug discovery segment accounted for the largest share of the application segment in the high-throughput screening (HTS) market in 2022.

Advertisement
Stake.com

Based on application, the high-throughput screening market is categorized into drug discovery, biochemical screening, life sciences research, and other applications. The drug discovery application segment accounted for the largest share of the high-throughput screening market in 2022. The key factor driving this segment’s growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.

North America was the largest regional market for high-throughput screening in 2022.

Geographically, the high-throughput screening market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In 2022, North America accounted for the largest share of the high-throughput screening market, followed by Europe and the Asia Pacific. The large share of North America in the global market is attributed to the increasing prevalence of diseases, rising pharmaceutical R&D expenditure, and the presence of major players in the region are factors driving the growth of the HTS market in this region.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950

High-Throughput Screening (HTS) Market Dynamics:

Advertisement
Stake.com

Drivers:

  1. The growing adoption of open innovation models in pharmaceutical & biotechnology companies
  2. Government funding and venture capital investments
  3. Increasing R&D spending
  4. Technological advancements in the HTS market

Restraints:

  1. The capital-intensive nature of HTS instruments
  2. Complexities in assay development

Opportunities:

  1. Emerging markets
  2. Growing applications in stem cell research

Challenges:

  1. The dearth of skilled operators

Key Market Players:

Key players in the high-throughput screening (HTS) market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Trading AG (Switzerland), AXXAM S.p.A (Italy), Promega Corporation (US), Bio-Rad Laboratories, Inc.(US), Promega Corporation (US), Hamilton Company (US), Corning Incorporated (US), Charles River Laboratories (US), Lonza (Switzerland), REPROCELL Inc. (Japan), Aurora Biomed (Canada), BMG LABTECH (Germany), DIANA Biotechnologies, s.r.o. (Czech Republic), NanoTemper Technologies GmbH (Germany), Creative Biolabs (US), Biomat Srl (Italy), HighRes Biosolutions (US), Cyclica Inc. (Canada), Crown Bioscience (US), and Sygnature Discovery (UK).

Recent Developments:

  • In February 2023, Agilent Technologies, Inc. launched the on-deck thermal cycler that integrates with the Agilent Bravo NGS automated liquid handling platform.
  • In February 2023, PerkinElmer Inc. launched the Multimode Plate Reader for high-throughput screening (HTS) applications and to accelerate drug discovery efforts.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=134981950

High-Throughput Screening (HTS) Market Advantages:

  • Accelerated Drug Discovery: High-throughput screening (HTS) expedites the drug discovery process by quickly screening a large number of compounds against specific targets. This speed enables researchers to identify potential drug candidates more rapidly, reducing the time and resources required for drug development.
  • Increased Efficiency: HTS employs automation, robotics, and advanced technologies, resulting in enhanced efficiency and productivity. The automated systems can handle multiple samples simultaneously, reducing manual labor and minimizing human error. This streamlines the screening process, allowing researchers to screen thousands or even millions of compounds in a shorter time frame.
  • Comprehensive Screening: HTS offers a systematic and comprehensive approach to screening compounds. By screening a vast library of compounds, including diverse chemical structures and natural products, HTS increases the likelihood of identifying compounds with desired biological activities. This broad exploration expands the possibilities for discovering novel drug candidates.
  • Target-specific Screening: HTS enables researchers to target specific molecular pathways or cellular functions, allowing for more focused screening. This approach increases the chances of identifying compounds that interact with the desired targets, leading to the discovery of potential therapeutics with specific mechanisms of action.
  • Cost-effectiveness: Although the initial setup costs of HTS can be significant, the long-term benefits often outweigh the investment. By streamlining the drug discovery process, HTS reduces costs associated with labor, reagents, and time. This cost-effectiveness makes HTS an attractive option for pharmaceutical companies and research institutions aiming to optimize their resources.
  • Innovation and Exploration: HTS fosters innovation by enabling researchers to explore vast chemical libraries and screen for various therapeutic targets. This approach encourages the discovery of new drug classes and expands the possibilities for developing treatments for challenging diseases.
  • Translational Research: HTS facilitates the translation of basic research findings into practical applications. By efficiently identifying potential drug candidates, HTS bridges the gap between academic research and clinical development, paving the way for the development of new treatments and therapies.
  • Beyond Pharmaceutical Applications: HTS has expanded beyond traditional drug discovery and found applications in other fields such as personalized medicine and agricultural research. In personalized medicine, HTS allows for the screening of patient samples to identify tailored treatment options. In agriculture, HTS enables the screening of compounds for crop improvement and disease resistance, optimizing agricultural practices.

In summary, the advantages of the HTS market lie in its ability to accelerate drug discovery, increase efficiency, facilitate comprehensive and targeted screening, offer cost-effectiveness, drive innovation, support translational research, and extend its applications beyond pharmaceuticals. These advantages position HTS as a valuable tool for advancing scientific research and improving human health.

High-Throughput Screening Market- Report Highlights:

Advertisement
Stake.com
  • Refinements in the segments of the global high-throughput screening market:
  • Company profiles give a glimpse of the key players in the market with respect to business overviews, financials, product offerings, and recent developments. The new edition of the report includes profiles for 25 companies. These companies include key market players and start-ups/mid-sized companies that have emerged in recent years due to the products they offer and various strategic investments undertaken in the high-throughput screening market space.
  • This report’s current edition provides updated financial information/product portfolios of players and updated developments of profiled players from January 2020 to June 2023. Expansions and product launches have been the principal growth strategies adopted by market players within this period.
  • The competitive landscape chapter has been updated with the market evaluation matrix. The competitive landscape also includes market share analysis, updated competitive leadership mapping, and competitive situations and trends.
  • In the new edition of the report, the Rest of the World is further divided into Latin America and the Middle East, and Africa.
  • The value chain analysis, supply chain analysis, ecosystem analysis, pricing analysis, porter’s fiver forces analysis, regulatory analysis and patent analysis were added in the market overview chapter.
  • In the product & service chapter, the instruments segment was further divided into liquid handling systems, detection systems, and other instruments. The consumables segment was also divided into reagents & assay kits, and laboratory equipment.
  • In the technology chapter, reporter-based assays, a new subsegment has also been added to the cell-based assays segment.
  • The biochemical screening and life sciences research segments were newly added to the application chapter of the current edition of the high-throughput screening market report.

Related Reports:

Lab Automation Market – Global Forecasts to 2028

Genomics Market – Global Forecasts to 2028

Drug Discovery Services Market – Global Forecasts to 2028

Liquid Handling System Market – Global Forecasts to 2027

Microfluidics Market – Global Forecasts to 2026

Advertisement
Stake.com

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Advertisement
Stake.com

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/high-throughput-screening-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/high-throughput-screening.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/high-throughput-screening-hts-market-worth-44-5-billion–marketsandmarkets-301870068.html

Continue Reading

Blockchain Press Releases

JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA CORPORATION AND NEW TICKER SYMBOL TO ALTS

Published

on

janone-confirms-name-change-to-alt5-sigma-corporation-and-new-ticker-symbol-to-alts

LAS VEGAS, July 13, 2024 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with a focus on fintech and healthcare, confirmed today that, as of market open on Monday, July 15, 2024, the Company’s new name will be “ALT5 Sigma Corporation” and its Nasdaq common stock ticker symbol will change to “ALTS”. This will replace the Company’s current ticker symbol “JAN”. Further, the Company’s website address will change from “janone.com” to “alt5sigma.com.”

The Company’s change of name, ticker symbol, and website address aligns with the Company’s realignment to focus on its recently acquired, ALT5 Sigma fintech as its core engine for revenue growth.

This realignment and changes in corporate name and the ticker symbol were previously announced on July 10, 2024. No action by the Company’s stockholders is required with respect to the ticker symbol change. The Company’s CUSIP number and transfer agent will remain unchanged.

Marking the changes confirmed today, Tony Isaac, Company CEO, observed, “We are pleased to complete the changes to our name and ticker symbol as the initial steps in our previously announced diversification into fintech, while keeping our biotech’s trajectory on track, all for the benefit of our stockholders.”

About JanOne/ALT5 Sigma

Advertisement
Stake.com

The Company is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. The Company is one of the constituents of the Russell Microcap Index, starting June 28, 2024.

Through its fintech activities, the Company provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm for the trading, clearing, settlement, payment, and custodianship of digital instruments. Through its fintech subsidiaries, the Company offers two main platforms to its customers: “ALT5 Pay” and “ALT5 Prime”. The subsidiaries processed over US$1.2 billion in cryptocurrency transactions in 2023.

ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay’s checkout widgets and APIs. Merchants have the option to convert to fiat currency (s) automatically or to receive their payment in digital assets.

ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named “ALT5 Pro” that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime’s FIX API, as well as through Broadridge Financial Solutions’ NYFIX gateway for approved customers.

Through its biotech activities, the Company is developing innovative, actionable solutions intended to help end the opioid crisis. The Company is dedicated to funding resources toward innovation, technology, and education to find a key resolution to the national opioid epidemic, which is one of the deadliest and most widespread in the nation’s history. Its drugs in the clinical trial pipeline have shown promise for their innovative targeting of the causes of pain as a strategic option for physicians averse to exposing patients to addictive opioids.

Advertisement
Stake.com

Forward Looking Statements

This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the profitability and prospective growth of ALT5’s platforms and business, that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5’s services, and technology challenges for future growth or expansion. This press release also contains statements and links relating to risks that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the commencement of clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, and other statements, including words such as “continue”, “expect”, “intend”, “will”, “hope”, “should”, “would”, “may”, “potential”, and other similar expressions. Such statements reflect the Company’s current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies.

Many factors could cause the Company’s actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company’s periodic reports filed with the Securities and Exchange Commission (the “SEC”). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled “Risk Factors” in the Company’s filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.

Media Contact Investor Relations
[email protected]
1-800-400-2247

Logo – https://mma.prnewswire.com/media/973662/JanOne_With_4C_TM_Logo.jpg 

Advertisement
Stake.com

Cision View original content:https://www.prnewswire.co.uk/news-releases/janone-confirms-name-change-to-alt5-sigma-corporation-and-new-ticker-symbol-to-alts-302196185.html

Continue Reading

Blockchain Press Releases

Battle for Glory at Bybit Web3’s Ultimate Memecoin Arena: Compete to Win $50,000 in Prize Pools

Published

on

battle-for-glory-at-bybit-web3’s-ultimate-memecoin-arena:-compete-to-win-$50,000-in-prize-pools

DUBAI, UAE, July 12, 2024 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is thrilled to announce the launch of its blockchain clash competition: the Ultimate Memecoin Arena (UMA). This event will showcase a thrilling showdown between two heavyweight meme tokens, Ponke and Brett, representing Solana and Base — two blockchains battling to be the main venue for memecoin launches and trading.

Kicking off on Jul. 11, 2024, at 10AM UTC, and running through Jul. 25, 2024, participants will engage in an epic clash between Solana and Base by supporting their favorite coin from their chosen blockchain. This trading competition is not just for the individual, by siding with the top team, participants will grab the Ultimate Prize Pool for their team.

Prize Pools:

  1. PONKE Prize Pool: $12,500 worth of PONKE tokens
    1. Eligibility: Trade at least $300 worth of PONKE tokens to qualify for a share of this pool.
  2. BRETT Prize Pool: $12,500 worth of BRETT tokens
    1. Eligibility: Trade at least $300 worth of BRETT tokens to qualify for a share of this pool.
  3. Ultimate Prize Pool: $25,000 worth of PONKE & BRETT tokens
    1. The pool with the highest trading volume will win the entire Ultimate Prize Pool.
    2. Rewards will be distributed among participants who have traded at least $300 of the winning token.

How to Participate:

  1. Prepare your Bybit Cloud Wallet or any Seed Phrase Wallet.
  2. Transfer SOL to your wallet for the PONKE Prize Pool or WETH for the BRETT Prize Pool.
  3. Swap at least $300 worth of PONKE or BRETT tokens to be eligible for their respective prize pools.
  4. Engage in trading to contribute to the Ultimate Prize Pool.

The trading competition is the first to be held on Bybit Web3 DEX Pro, a revolutionary decentralized exchange with over 1 million tokens to trade modeled after Bybit’s institutional-grade trading interface. Bybit Web3 DEX Pro surpasses typical CEX offerings, equipping users with i-SMART data intelligence technology. This powerful suite provides traders with on-chain and social media data, allowing them to make informed and smarter decisions.

“This competition is about embracing the excitement and community spirit of the crypto world,” said MK Chin, Bybit Web3 evangelist. “We’re excited to see how participants strategize and trade their way to victory in this thrilling competition.”

Don’t miss your chance to participate in the Ultimate Memecoin Arena and compete for glory and substantial rewards. Join Bybit in the battle of the meme tokens and trade your way to victory!

Advertisement
Stake.com

#Bybit / #TheCryptoArk

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving over 33 million users. Established in 2018, Bybit provides a professional platform where crypto investors and traders can find an ultra-fast matching engine, 24/7 customer service, and multilingual community support. Bybit is a proud partner of Formula One’s reigning Constructors’ and Drivers’ champions: the Oracle Red Bull Racing team.

For more details about Bybit, please visit Bybit Press.

For media inquiries, please contact: [email protected]

Advertisement
Stake.com

For more information, please visit: https://www.bybit.com

For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

Bybit Logo

Photo – https://mma.prnewswire.com/media/2460020/Image.jpg
Logo – https://mma.prnewswire.com/media/2267288/Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/battle-for-glory-at-bybit-web3s-ultimate-memecoin-arena-compete-to-win-50-000-in-prize-pools-302195749.html

Continue Reading

Blockchain Press Releases

Bybit Web3 and Ignition Join Forces to Bridge the Gap Between Bitcoin and Ethereum

Published

on

bybit-web3-and-ignition-join-forces-to-bridge-the-gap-between-bitcoin-and-ethereum

DUBAI, UAE, July 12, 2024 /PRNewswire/ — Bybit, the world’s second-largest web3 platform by trading volume, breaks down barriers between Bitcoin and the Ethereum Virtual Machine (EVM) ecosystems with its partnership of Ignition. Supported by core contributors Mantle and Antalpha Prime, Ignition is paving the way for a low-friction and interoperable future. It extends Bitcoin’s functionality beyond its traditional role as a store of value and transforms it into a reliable asset for cross-chain integrations and diverse yield opportunities.

Bybit Web3 Wallet will support FBTC, an omnichain Bitcoin asset pegged 1:1 to BTC, introduced by Ignition. This strategic collaboration empowers users to unlock the full potential of Bitcoin within the thriving EVM ecosystem, reflecting Bybit Web3’s philosophy of openness, simplicity, and equality.

“We are thrilled to partner with Ignition, which aligns with Bybit’s mission to provide users with innovative and seamless DeFi solutions. By integrating Ignition and FBTC, we are not only enhancing liquidity and interoperability but also paving the way for a more inclusive and dynamic crypto ecosystem,” added MK Chin, Bybit Web3 Evangelist.

FBTC: Bridging the Divide between Bitcoin and non-Bitcoin Ecosystems in Web3

Introduced by Ignition, FBTC is an omnichain Bitcoin asset pegged 1:1 to BTC aimed at elevating Bitcoin’s accessibility and utility. As a secure, decentralized, and composable liquid Bitcoin asset with deep liquidity, $FBTC can be used at scale and easily integrated into various yield enhancement strategies like liquidity pooling, collateral, and staking.

Advertisement
Stake.com

Under Ignition, $FBTC’s growth will be driven by a comprehensive roadmap and strong developer support, ensuring its long-term success and sustainable growth.

Bybit Web3: A Partnership for Enhanced DeFi and User Opportunities

Bybit is at the forefront of adopting the Ignition ecosystem, reinforcing Bybit’s commitment to pioneering innovative solutions for the crypto community. Bybit Web3 users will now have access to a multitude of products and opportunities within the burgeoning Ignition space. 

This integration unlocks a range of benefits for users:

  • Enhanced Liquidity: FBTC opens the door to increased liquidity, allowing users to trade and invest in Bitcoin with greater ease within the EVM ecosystem.
  • Diverse Yield Opportunities: Users can explore a variety of attractive yield-generating strategies with FBTC, maximizing the earning potential of their Bitcoin holdings.
  • Seamless Interoperability: FBTC bridges the gap between various blockchain networks, ensuring users can move their assets freely and efficiently.

Coming Soon: Swap and Staking on FBTC

Bybit Web3 users can look forward to using their Bybit Web3 Wallet to swap and stake on FBTC in the later half of July. For more information, please visit: https://www.bybit.com/en/web3/home

Advertisement
Stake.com

#Bybit / #TheCryptoArk / #BybitWeb3

About Bybit Web3

Bybit Web3 is redefining openness in the decentralized world, creating a simpler, open, and equal ecosystem for everyone. We are committed to welcoming builders, creators, and partners in the blockchain space, extending an invitation to both crypto enthusiasts and the curious, with a community of over 10 million wallet users, over 20 major ecosystem partners, and counting. 

Bybit Web3 provides a comprehensive suite of Web3 products designed to make accessing, swapping, collecting and growing Web3 assets as open and simple as possible. Our wallets, marketplaces and platforms are all backed by the security and expertise that define Bybit as a top 3 global crypto exchange, trusted by 33 million users globally.

Join the revolution now and open the door to your Web3 future with Bybit.

Advertisement
Stake.com

For more details about Bybit, please visit Bybit Web3.

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving over 33 million users. Established in 2018, Bybit provides a professional platform where crypto investors and traders can find an ultra-fast matching engine, 24/7 customer service, and multilingual community support. Bybit is a proud partner of Formula One’s reigning Constructors’ and Drivers’ champions: the Oracle Red Bull Racing team.

For more details about Bybit, please visit Bybit Press.
For media inquiries, please contact: [email protected]
For more information, please visit: https://www.bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

Advertisement
Stake.com
Bybit Web3 Logo

Photo – https://mma.prnewswire.com/media/2459975/Image.jpg
Logo – https://mma.prnewswire.com/media/2311075/Bybit_Web3_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/bybit-web3-and-ignition-join-forces-to-bridge-the-gap-between-bitcoin-and-ethereum-302195724.html

Continue Reading
Advertisement
Stake.com
Advertisement

Latest News

Recent Listings

  • Global Payout, Inc.

    Since the Company’s inception in 2009, Global Payout, Inc. has been a leading provider of compreh...

  • MTrac Tech Corp.

    MTrac Tech Corporation, a Nevada Corporation, is a privately held, wholly owned subsidiary of Glo...

  • Net1

    Net1 is a leading provider of transaction processing services, financial inclusion products ...

  • uBUCK Technologies SEZC

    Based in Georgetown, Cayman Islands, uBUCK Tech is a fintech enterprise that specializes in digit...

  • LiteLink Technologies Inc.

      LiteLink is a major player in developing world-class enterprise platforms that utilize ar...

  • Good Gamer Corp.

      Good Gamer Corp. is a privately-held technology company focusing on gamers and streamers....

  • BitPay

      Founded in 2011, BitPay pioneered blockchain payment processing with the mission of trans...

  • About Net1

      Net1 is a leading provider of transaction processing services, financial inclusion produc...

  • Blockchain Foundry Inc.

    Headquartered in Toronto, Canada, Blockchain Foundry (CSE:BCFN)(FWB:8BF)(OTC:BLFDF) is a global b...

  • Sixgill

    Sixgill provides a full suite of universal data automation and authenticity products and services...

Trending on TBE